These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12606129)

  • 21. Comparative genomic hybridization analysis of hepatoblastomas: additional evidence for a genetic link with Wilms tumor and rhabdomyosarcoma.
    Steenman M; Tomlinson G; Westerveld A; Mannens M
    Cytogenet Cell Genet; 1999; 86(2):157-61. PubMed ID: 10545709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of apoptosis, cell proliferation, and drug resistance genes in pediatric Wilms' tumors.
    Ramachandran C; Melnick SJ; Escalon E; Jhabvala P; Khatib Z; Alamo A; Smith S
    Anticancer Res; 2000; 20(5C):3759-65. PubMed ID: 11268451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perilobar nephrogenic rests and chromosome 22.
    Mdzin R; Phillips M; Edwards C; Murch A; Charles A
    Pediatr Dev Pathol; 2011; 14(6):485-92. PubMed ID: 21864120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
    Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
    Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paired box gene expression in Wilms' tumor.
    Tagge EP; Hanson P; Re GG; Othersen HB; Smith CD; Garvin AJ
    J Pediatr Surg; 1994 Feb; 29(2):134-41. PubMed ID: 7909843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK; Brown KW; Berry PJ
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cytogenetic study of Wilms' tumor.
    Slater RM; de Kraker J; Voûte PA; Delemarre JF
    Cancer Genet Cytogenet; 1985 Jan; 14(1-2):95-109. PubMed ID: 2981155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identical genetic changes in different histologic components of Wilms' tumors.
    Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
    J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic findings in Wilms' tumour: a single institute study.
    MdZin R; Murch A; Charles A
    Pathology; 2010 Dec; 42(7):643-9. PubMed ID: 21080873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20.
    He X; Ee PL; Coon JS; Beck WT
    Clin Cancer Res; 2004 Jul; 10(14):4652-60. PubMed ID: 15269137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors.
    Waber PG; Chen J; Nisen PD
    Cancer; 1993 Dec; 72(12):3732-8. PubMed ID: 8252491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
    Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
    Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosome analyses of 16 cases of Wilms tumor: different pattern in unfavorable histology.
    Peres EM; Savasan S; Cushing B; Abella S; Mohamed AN
    Cancer Genet Cytogenet; 2004 Jan; 148(1):66-70. PubMed ID: 14697643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
    Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
    Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline and somatic abnormalities of chromosome 7 in Wilms' tumor.
    Wilmore HP; White GF; Howell RT; Brown KW
    Cancer Genet Cytogenet; 1994 Oct; 77(2):93-8. PubMed ID: 7954327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetic findings and clinical course in a consecutive series of Wilms tumors.
    Kullendorff CM; Soller M; Wiebe T; Mertens F
    Cancer Genet Cytogenet; 2003 Jan; 140(1):82-7. PubMed ID: 12550766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic changes of two Wilms tumors with anaplasia and a review of the literature suggesting a marker profile for therapy resistance.
    Stock C; Ambros IM; Lion T; Zoubek A; Amann G; Gadner H; Ambros PF
    Cancer Genet Cytogenet; 2002 Jun; 135(2):128-38. PubMed ID: 12127397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic changes in the WT-gene (WT1) in Wilms' tumors and their correlation with histology.
    Kikuchi H; Akasaka Y; Nagai T; Umezawa A; Iri H; Kato S; Hata J
    Am J Pathol; 1992 Apr; 140(4):781-6. PubMed ID: 1314024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosome analysis of 31 Wilms' tumors.
    Sheng WW; Soukup S; Bove K; Gotwals B; Lampkin B
    Cancer Res; 1990 May; 50(9):2786-93. PubMed ID: 2158398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.